Journals / Turkish Journal of Gastroenterology / 2016 / Cilt: 27 - Sayı: 2

Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients

Pages
205–206
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KAHVECİ, A. S., TAHAN, V. (2016). Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients. Turkish Journal of Gastroenterology, Cilt: 27 - Sayı: 2, 205–206. https://ajindex.com/articles/410220

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Feld JJ, Jacobson IM, Hézode C, et al. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. N Engl J Med 2015; 373: 2599-607. [CrossRef] Foster GR, Afdhal N, Roberts SK, et al. Sofosbuvir and Velpatas- vir for HCV Genotype 2 and 3 Infection. N Engl J Med 2015; 373: 2608-17. [CrossRef]